Hepatotoxicity of halogenated inhalational anesthetics

Abstract EN

Context : Halogenated inhalational anesthetics are currently the most common drugs used for the induction and maintenance of general anesthesia.

Postoperative hepatic injury has been reported after exposure to these agents.

Based on much evidence, mechanism of liver toxicity is more likely to be immunoallergic.

The objective of this review study was to assess available studies on hepatotoxicity of these anesthetics. Evidence Acquisition : We searched PubMed, Google Scholar, Scopus, Index Copernicus, EBSCO and the Cochrane Database using the following keywords: “inhalational Anesthetics” and “liver injury”; “inhalational anesthetics” and “hepatotoxicity”; “volatile anesthetics” and “liver injury” ; “volatile anesthetics” and hepatotoxicity for the period of 1966 to 2013.

Fifty two studies were included in this work. Results : All halogenated inhalational anesthetics are associated with liver injury.

Halothane, enflurane, isoflurane and desflurane are metabolized through the metabolic pathway involving cytochrome P-450 2E1 (CYP2E1) and produce trifluoroacetylated components; some of which may be immunogenic.

The severity of hepatotoxicity is associated with the degree by which they undergo hepatic metabolism by this cytochrome.

However, liver toxicity is highly unlikely from sevoflurane as is not metabolized to trifluoroacetyl compounds. Conclusions : Hepatotoxicity of halogenated inhalational anesthetics has been well documented in available literature.

Halothane-induced liver injury was extensively acknowledged ; however, the next generation halogenated anesthetics have different molecular structures and associated with less hepatotoxicity.

Although anesthesia-induced hepatitis is not a common occurrence, we must consider the association between this disorder and the use of halogenated anesthetics.